Corteva, Inc. $CTVA Holdings Boosted by Metis Global Partners LLC

Metis Global Partners LLC boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 8.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 116,389 shares of the company’s stock after acquiring an additional 8,819 shares during the period. Metis Global Partners LLC’s holdings in Corteva were worth $7,802,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in Corteva by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after acquiring an additional 317,538 shares during the last quarter. State Street Corp lifted its holdings in Corteva by 3.6% in the third quarter. State Street Corp now owns 35,280,805 shares of the company’s stock worth $2,386,041,000 after acquiring an additional 1,230,074 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Corteva by 4.3% in the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares during the last quarter. Northern Trust Corp lifted its holdings in Corteva by 1.8% in the third quarter. Northern Trust Corp now owns 11,169,284 shares of the company’s stock worth $755,379,000 after acquiring an additional 194,728 shares during the last quarter. Finally, Norges Bank bought a new position in Corteva in the fourth quarter worth about $504,001,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE CTVA opened at $74.59 on Thursday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm has a market capitalization of $49.89 billion, a PE ratio of 43.88, a P/E/G ratio of 2.29 and a beta of 0.57. The company’s 50 day simple moving average is $80.72 and its 200 day simple moving average is $75.24.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business earned $1.13 earnings per share. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analyst Ratings Changes

A number of brokerages have issued reports on CTVA. Jefferies Financial Group raised their target price on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Citigroup lifted their price target on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Morgan Stanley lifted their price target on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Royal Bank Of Canada lifted their price target on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, The Goldman Sachs Group lifted their price target on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $88.48.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.